Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

Fig. 3

Cross-tab analysis and χ2 tests showing modifications of cryocrit, rheumatoid factor (RF), C4 and ALT levels in relation to antiviral therapy. Besides hepatitis C virus RNA, cryocrit and ALT values were significantly influenced by therapy with respect to RF and C4 (p < 0.0001 and p < 0.0001, respectively). ALT Alanine transaminase, C4 Complement component C4, EoT End of treatment, SVR12 Sustained virological response 12 weeks after therapy completion

Back to article page